Poly Medicure appoints Indranil Mukherjee as CEO - Asia Pacific and India Business

Ceo Appointed ExternalManagement Changes View source PDF Explain this filing

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹1325.00

prior close

₹1323.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.7% vs market

Medical Equipment & Supplies peers, median of 12sector+0.4%-0.6% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Smallcap 250 and 0.6 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-0.4

15m

-0.9

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2+0.5-0.7+0.4-0.6

Next day

+1.3+0.6+0.7-1.0+2.3

+6.8+1.2+5.6-1.5+8.3

+7.2+1.2+6.0-0.7+7.9

+4.5-0.6+5.1-2.0+6.5

+10.7+0.7+10.0-3.2+13.9

+12.1-1.3+13.3-3.9+15.9

15d

+24.6+5.3+19.3-1.1+25.7

+30.9+6.7+24.2+2.0+28.9

+28.7+7.8+21.0+0.9+27.8

+35.1+8.3+26.8+2.3+32.7

UpDownMarket · Nifty Smallcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Poly Medicure has appointed Mr. Indranil Mukherjee as Chief Executive Officer for Asia Pacific and India Business, effective June 1, 2026. He is categorized as Senior Management Personnel and will report directly to the Managing Director. Mukherjee brings over 30 years of medical technology leadership experience, previously serving as Managing Director at B. Braun India and Group CEO at Translumina Therapeutics, with expertise across critical care, infusion therapy, and surgical devices.

Likely market impact

External hire of seasoned medical devices leader signals focus on scaling Asia Pacific operations and driving profitable growth across the India business.